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Venomous and Poisonous Animals. A
Handbook for Biologists, Toxicologists and
Toxinologists, Physicians and Pharmacists
By Dietrich Mebs. Pp. ix  + 339. Illustrated. Euro 86.0/Sw.fr. 137.60.
Medpharm Scientific Publishers. 2002. ISBN 3-88763-093-9.
This book is a translation and major update of Mebs Gifttiere
published in 1989. The content is, however, so different from
the original, that this is essentially a new book. The translation
is excellent, apart from a few quaint phrases, including an
amusing acknowledgement of the excellence of the 'Englisch'
translation. The design is attractive, with an opening section
that introduces toxins and venoms, followed by two major
sections covering respectively marine and terrestrial animals.
Although short, the first section has a wealth of intriguing
information. Examples include the extraordinary diversity of
unrelated animals that make use of tetrodotoxin (sea snails,
fish, toads, starfish and even birds), the arms race between
predators and their prey, and the remarkable array of functions
fulfilled by venoms and toxins. The second and third parts run
systematically through the major groups of animals, with
individual coverage and superb photographs of the most
important species.
For most toxins and venoms, there are no antidotes, and
practical symptomatic treatments are recommended —
reassurance, immobility, elevation of the legs, mouth-to-mouth,
external cardiac massage, avoidance of cutting, pressure or
tourniquets. Some of the recommendations surprised me, such
as the avoidance of heat or cold as a means of treatment,
despite the relief they bring and the fact that these treatments
are advocated by many other authorities. A strong stance is
taken against herbal drugs and treatments by local healers and
shamans, and against carrying antivenoms for snakebite
because of the risks of degeneration and anaphylactic shock.
For each species or group of animals details are provided
about how envenoming takes place, preventive measures, the
nature of the venom or toxin, reactions and treatments. Case
histories and treatments provide more specific details.
I learnt a great deal from the book and had to discard some
long-cherished beliefs about the effectiveness of various
treatments. The most important attribute of the book is that it
provides a single, authoritative, up-to-date and reasonably
comprehensive coverage. Paradoxically, that is also a weakness.
Not all of the targeted audience of 'biologists, toxicologists,
toxinologists, physicians and pharmacists' embraced in the
subtitle of the book will find sufficient detail to satisfy their
disparate backgrounds and needs. In fairness, though, the
references that are cited do provide access to more detailed
literature.
I found the book attractive, enlightening and a welcome and
overdue review of the topic.
George Branch
Advances in End-Stage Renal Disease 2003.
Renal Research Institute Seminars
Edited by C Ronco and NW Levin. Pp. iv + 140. Illustrated.
CHF 112./EUR80./US$97.50. Hard Cover. KARGER. 2003. ISBN 3-
8055-7535-1.
This is a publication of presentations from a conference held in
Miami in January 2003.  It appears that the conference is an
annual event and specifically concentrates on advances in end-
stage renal disease (ESRD).  The obvious aim is to provide an
update on current technology and therapeutics in renal failure.
It will appeal to all nephrologists. Certain sections will be of
interest to those cardiologists involved in the management of
end-stage renal failure patients.  The topics vary but a few
points  are important.
The point is made that there is an urgent need to include
kidney transplant recipients in a comprehensive programme of
care (guided by kidney diseases outcomes quality initiative
(K/DOQI). This is with a view to attempt to improve patient
outcome post-transplantation — particularly if the transplant
fails and the patient returns to dialysis.  Little attention is paid
to the fact that they have been on steroids and are at increased
risk from cardiovascular and bone disease. 
There is no doubt that cardiovascular disease is accelerated
in renal failure patients. The pathogenesis involves, among
others, the effect of anaemia on myocardial function.
Congestive heart failure may result from progressive hypoxic
cardiac damage.  The section dealing with atherosclerosis in
ESRD is very well done.  Arterial damage in ESRD is
accelerated by risk factors that are peculiar to end-stage kidney
failure.  They are anaemia, secondary hyperparathyroidism
and exposure to bioincompatible dialysis membranes.  The
other novel risk factors are hyperhomocysteinaemia and the
acute phase reactants like C-reactive protein, all the cytokines,
interleukin B, tumour necrosis factor (TNF) α and interleukin 6.
They are independently associated with atherosclerosis and
death in ESRD patients.  The information presented in Miami
underlined the notion that atherosclerosis is an inflammatory
condition and that ESRD is actually ‘pro-inflammatory’.
Therapeutic possibilities such as angiotensin inhibition, anti-
lipid agents together with anti-oxidants and antibiotic
prescription are mentioned.
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The ‘old’ question as to what constitutes a good assay for
parathyroid hormone (PTH) levels in renal failure is once again
asked.  Again there is no firm conclusion; the second
generation PTH assays are not as effective as the first
generation immunometric PTH assays in predicting bone
histology in patients with ESRD (since they have not been
around long enough).  This particular section makes for very
interesting reading with regard to the difference between the
assays. 
Peritoneal dialysis (PD) is well covered. The big ADEquacy
study in MEXico (ADEMEX study) was discussed at great
length and it is interesting to note the criticisms of the study,
such as that the rapid transporters and small patients were not
included — these excluded patients who had been found to
have an increased relative risk of death in other PD studies.
The ADEMEX evaluation looked at small solute clearance but
not at middle molecule weight clearances and their influence
on outcome.  There were no evaluation outcomes on patients
on cycler therapies.  This should not be too much of a problem
for us since, in South Africa, automated therapies are
unaffordable by the majority of our chronic renal failure
patients.  Nevertheless this study was well designed and the
message is that one must individualise dialysis prescriptions.
The effect of the glucose in dialysate fluid is discussed; the
formation of advanced glycosylated end products (AGE) is
considered to be the principal reason for the deleterious
changes in the peritoneal membrane.  The histological changes
in the membrane resemble the pathology found in individuals
with longstanding diabetes. Biocompatible dialysis solutions
are required to care adequately for our continuous ambulatory
peritoneal dialysis (CAPD) patients. 
The removal of toxins (extracorporeal blood purification
therapies (EBPT)) in ‘non-renal critical illness’ using, among
others, haemofiltration, haemadsorption and haemodialysis is
presented.  It seems that many of the discussions are still very
theoretical and we will need to wait for further studies before
there is any clarity on the role of this approach in septic
patients.
Charles Swanepoel
We Miss You All — Noerine Kaleeba:
AIDS in the Family
2nd edition. Noerine Kaleeba and Sunanda Ray. Pp. xii + 124.
Illustrated. US$8. SAfAIDS. 2002. ISBN 0-7974-2525X.
'AIDS came to my house on the afternoon of the 6th June 1986,'
says Noerine in the stark matter-of-fact way which
characterises this book. A physiotherapist in Kampala, Uganda,
Noerine's husband Chris was in Hull in the UK doing
postgraduate training in education on a British Council
scholarship. Doctors in Hull had diagnosed AIDS, at that stage
still a relatively new disease, although Uganda was already
starting to see the effects of what would become its epidemic.
Chris contracted HIV through a blood transfusion from his
younger brother Godfrey in July 1983, after a traffic accident.
Godfrey died early in 1984, after a long illness which no-one
realised was AIDS. Within months of the transfusion, Chris
himself developed a skin rash and sores in his throat, was tired
all the time and not his normal self. No-one suspected HIV.
We Miss You All is a searing account of one woman's
experience of HIV and AIDS and its effects on her family. Chris
died on 23 January 1987, aged only 39. 'He died in a lot of
pain,' said Noerine. 'I can't understand why he had so much
pain.' This was the beginning of her attempt to come to terms
with his death and with the reality of HIV infection in her
home and in the community. In a country where the infection
was still regarded with fear and suspicion, Noerine decided to
come out into the open about HIV in her family. Although HIV
negative herself, she chose to live as though she were positive,
in her words, 'I chose to live positively'. It was not enough to
bring her family through the tragedy. She wanted to do more
for others living with the virus. In 1987 The AIDS Support
Organisation (TASO) was founded with 16 people, 12 of them
living with AIDS. They wanted the word AIDS in the name to
break the silence and stigma of the disease.
By 1996, Noerine had done so much against HIV in Uganda
that she was approached by UNAIDS to join them in Geneva.
She describes her first years at UNAIDS as 'inspirational'. They
were a small team dedicated to persuading the United Nations
of the importance of the growing pandemic in Africa.
But in spite of her international movements, Noerine never
lost sight of her family and AIDS did not stop with her
husband. Her sister Rose died of AIDS in 1992, Rose's husband
dying soon afterwards. Her sister Harriet's husband also died
of the virus, while Harriet struggles to live with HIV. Her
brother Andrew, his wife and Noerine's niece were all
diagnosed with HIV. Her niece died in 1995. Altogether, she
has lost 12 family members to HIV. Noerine now single-
handedly looks after the 14 children they left.
The Words 'We miss you all' are inadequate to express the
feelings of those left behind in the aftermath of the HIV
pandemic in Africa. This little book goes a long way towards
bringing a human face to the statistics which now fail to shock,
being almost unimaginable.
Bridget Farham
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